Tumour-associated fibroblasts (TAFs) 
Introduction
Beginning with the work of Friedenstein and colleagues almost four decades ago [1] , the concept of adult mesenchymal stem cells (MSCs) [6] , reinforcing again the importance of the supportive role of the stromal background for the malignant cells [7] . Although the tumour-associated stroma comprises four main components -vasculature, inflammatory cells, extracellular matrix and TAFs [8] [9] , are recruited from the bone marrow [10, 11] or from the local healthy tissue during tumour development. For instance, Spaeth et al. [6] (Fig. 1) . (Fig. 2) .
Materials and methods

Cell isolation and culture
ELISA
An ELISA analysis was performed with Quantikine Immunoassay kits (R&D Systems, Minneapolis, MN, USA) specific for interleukin (IL)-4, IL-10, IL-13, TGF-␤1, tumour necrosis factor (TNF)-␣, interferon (IFN)-␥ and vascular endothelial growth factor (VEGF). Most of the TGF-␤1 were secreted by the cells in a latent
RNA extraction and qRT-PCR
Results
Microscopy of MSCs and fibroblasts
m). Square mark in (A) is enlarged in (B). Note in (B) that intermediate filaments are organized in bundles which generate the 'light' appearance of the cell. The TAFs (C and D) have abundant rough endoplasmic reticulum (rer), enlarged smooth endoplasmic reticulum (ser), numerous lysosomes (ly) and grouped filopodia (arrows). Numerous lysosomes with multilamellar structure are visible in (D) [enlarged square area from (C)].
Fig. 2 Flow cytometry analysis of cell surface markers expression on
Although MSCs are essentially defined by their lack of HLA-DR, we have found low levels of expression on both MSC and TAFs at all analysed passages. This is suggestive for their activated status [12] [13] [14] . [15, 16] (Fig. 4) . Fig. 5A and  B) . We did not perform the differentiation experiments with the other types of fibroblasts (HDFa and skin fibroblasts), their pluripotent abilities being well documented in the literature [17] [18] [19] . (Fig. 6) . (Fig. 9) . As our ELISA procedure involves a MSCs. Magnification, 200x. step that converts all the latent TGF-␤1 to the active form that will actually be detected, it is not possible to estimate the amount of the active form, if any, produced ab initio by the cells.
No cytokeratin and E-cadherin expression were detected by either flow-cytometry or immunohistochemistry (IHC). As revealed by IHC, both TAFs and MSCs strongly expressed vimentin (Fig. 3), with cytoplasmic and perinuclear localization. Vimentin is a defining cytoskeletal protein found in connective tissues and all primitive cell types express vimentin; however, in most non-mesenchymal cells, it is replaced by other intermediate filament proteins during differentiation
. It is interesting that vimentin expression does not decrease during the more advanced passages of TAFs (data not shown), suggesting that they retain their 'primitive' MSC-like status. Regarding the proliferation rate of MSCs, TAFs and HDFa, the MTT assay showed that the proliferation rate of the MSCs was significantly lower than that of TAFs and HDFa (P Ͻ 0.001), and the results were correlated with cell count and viability testing using Trypan Blue vital staining, which was performed in parallel
Plasticity of TAFs compared to MSCs
Adipogenesis was markedly induced in MSCs after exposure to specific culture medium (50% of cells presented lipid drops within the cytoplasm); differentiation of TAFs towards the adipocytic lineage was weaker (30%), although TAFs presented an earlier phase differentiation, with few adipocytes appearing in the culture after 1 week of exposure to differentiation medium. Visualization of TAFsdifferentiated adipocytes was performed with primary mouse antihuman FABP4 antibody coupled with AlexaFlour 488 (Fig. 5C). Upon induction of both MSCs and TAFs to differentiate towards osteoblasts and chondrocytes, no differences between the differentiation patterns were observed, as both cell types showed the expression of osteocalcin and aggrecan when immunostained with flourochrome-conjugated primary specific antibody (
TAFs secrete growth factors and cytokines that support tumour cells proliferation
MSCs secreted much lower amounts of cytokines with direct immunosuppressive effects, such as IL-10, when compared to TAFs (P Ͻ 0.001), with their secretion level being similar to HDFa and skin-isolated fibroblasts (Fig. 7). The immunoinhibitory effects of MSCs are well described, and it is not surprising that these become even more potent upon activation and transition to TAFs, in response to signals received within the tumour microenvironment. On the other hand, IL-13 production seems to be similar among the various fibroblasts and insignificantly higher compared to that of MSCs. IL-4 and TNF-␣ secretion by TAFs is significantly higher than MSC production of both cytokines (P Ͻ 0.001), and it is similar to that of the other fibroblasts (Fig. 8). As expected, very low and similar levels of IFN-␥ were detected for all types of fibroblasts and MSCs (data not shown). Another cytokine potently secreted by TAFs is TGF-␤1, with its quantified level being almost twice as high compared to that of MSCs and HDFa cells
Fig. 3 Vimentin expression in TAFs (A) and MSCs (B), as revealed by immunohistochemistry with a specific antibody (clone V9). Vimentin is a generic marker used to define fibroblast cells and TAFs exhibit no visible difference in the expression of this marker compared to
TAFs activation-related proteins
The ␣-SMA expression in fibroblasts is variable and generally associated with an activated or 'aggressive' phenotype. qRT-PCR analysis has revealed, on average, a 10-fold higher expression of ␣-SMA in the breast tumour-derived TAFs, compared to the MSCs, suggesting the activated status of these fibroblasts (Fig. 10) . This is especially true for the early TAF passages; however, ␣-SMA expression seems to decrease significantly to the basic level found in MSCs, during the more advanced passages, perhaps in association with the loss of aggressive phenotype and/or the aging process.
Discussion
The fibroblasts, fibrovascular networks and soluble factors that comprise the tumour stroma, defining the tumoral microenvironment, are critical ingredients of a 'healthy' tumour, which is capable of long-term survival, proliferation and evolution. Although many 
